The global eubiotics market size is anticipated to reach USD 7.9 billion by 2028, expanding at a CAGR of 8.1%, according to a new report by Grand View Research, Inc. The growth in the market can be attributed to concerns over antibiotic traces in animal meat and their health hazards. Eubiotics also provides benefits such as increased feed conversion ratio, resistance to diseases, and better animal welfare. All these factors are expected to propel market growth over the forecast period.

Eubiotics are fast replacing antibiotics and there has been rising awareness pertaining to their usage across the globe. The shift in the trend toward the usage of antibiotic alternatives such as eubiotics is expected to benefit market growth. Additionally, favorable regulatory scenario banning the use of antibiotics as growth promoters has benefitted market growth in the recent past and is expected to do so in the near future.

Request Free Sample Report: https://www.grandviewresearch.com/industry-analysis/eubiotics-market

The feed additives are manufactured and are distributed either through feed mills, pre-mixers, or specific distributors. The companies involved in manufacturing these feed additives either sell their products directly to their consumers or sell them to integrated feed producers. Either way, the eubiotic products reach the livestock producers.

Eubiotics Market Report Highlights

• Concerns over antibiotic traces found in meat are expected to result in a rise in the usage of product by meat industry participants
• Development of customized products to suit specific applications, such as gut health, is a major market characteristic
• The outbreak of COVID-19 disease in Wuhan, China, in December 2019 has negatively influenced the Chinese markets as well as the economy. Shutdown of factories, trade bans, and domestic lockdowns are estimated to hamper market growth in the country over a short period
• The further spread of pandemic to U.S., India, Italy, Germany, and U.K. has blocked the raw material supply. China and India are the most affected countries in Asia and the key players in the market, has observed a complete lockdown of manufacturing units in the countries, which is estimated to result in the supply-demand gap in the short run.

Key Companies & Market Share Insights

Key players in the market are inclined towards high investments in R&D activities for the development of superior products having high efficacy and more enhanced products. The choice of eubiotics to be used is a matter of concern for livestock manufacturers. The choice mainly depends on the intended applications, the type of livestock, and the animal diet. The industry is also characterized by mergers and acquisitions and the opening of new facilities to better serve the regional market. For instance, a key player such as DSM has established dedicated animal nutrition centers in China to better serve the local needs and to increase the regional feed market. Favorable regulatory scenarios and the shift in trend towards the usage of alternatives of antibiotics are bound to attract new market entrants.

Strategies such as opening regional offices, manufacturing facilities, and R&D centers are adopted by companies to increase their regional footprint. For R&D, companies work in collaboration with research and educational institutes across the globe to gain a competitive advantage. Products specific to the applications such as yield and gut health have been developed by key players. Companies are focusing on developing regions, such as the Asia Pacific, for increasing their market share. Some of the prominent players in the eubiotics market include DSM N.V., Novus International, Inc., Nebraska Cultures, Inc., Lallemand, Inc., Calpis Co., Ltd., Advanced BioNutrition Corp., Beneo GmbH, Behn Meyer, Lesaffre Group, Kemin Industries

Browse Full Report (Tables & Figures) @ https://www.grandviewresearch.com/industry-analysis/eubiotics-market